Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News nDatalyze Corp C.NDAT

Alternate Symbol(s):  NDATF

Industrials
The Corporation is a Calgary-based company that recently initiated its new SHAMAN development; a validated-data-driven, machine-learning mHealth platform designed to provide, initially, proactive analysis of the potential of psychedelics in mental health treatment regimes. MXT derives cash flow from the manufacture and sale of it's patented craft-scale bio-extractors that can be used to extract compounds from a variety of botanical materials.


Stock Price Chart (CSE:NDAT)

Fundamentals Snapshot (CSE:NDAT)

Current News (CSE:NDAT)

nDatalyze Corp. ("NDAT" or the "Corporation") (CSE:NDAT) (OTC:NDATF) Provides an Operational Update for its YMI Machine Learning-Based Mental Health Assessment Program and Announces Initiation of its B2B Clinical Decision Support System ("CDSS") Program

TheNewsWire May 1, 2023

Operational Update

TheNewsWire March 21, 2023

Marketing Program Update - Phase 3, US market entry, begins

TheNewsWire February 28, 2023

Website Update and Presentation Reminder

TheNewsWire February 15, 2023

nDatalyze Corp. to Host Live Corporate Webinar on Thursday, February 16th, at 11am ET

TheNewsWire February 13, 2023

nDatalyze Corp. anticipates YMI ChatGPT testing

TheNewsWire January 25, 2023

nDatalyze Corp. announces two video initiatives to augment its Phase 2 marketing program.

TheNewsWire January 18, 2023

nDatalyze Corp. Releases its Breakthrough A.I.-driven Predictive Analysis Tool, Empowering People with a Clearer Picture of Their Own Mental Health

TheNewsWire December 7, 2022

YMI marketing campaign update and Annual General and Special Meeting Results

TheNewsWire December 6, 2022
View More News ››

Opinion & Analysis (CSE:NDAT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:NDAT)

RE:Small steps

In the current market we should see a double from here, given the current societal focus on mental health. Currently a 8 million market...
Brianw21 - November 19, 2021

Small steps

Starting to move up a little bit at a time.
kenoplayer - November 19, 2021
View more Bullboard ››

Eminent Gold Corp

Eminent Gold Corp

Eminent Gold Corp is engaged in the exploration and evaluation of resource properties. The projects of the company include ...
View More »